TARDBP and amyotrophic lateral sclerosis: In another preclinical study using TDP-43 transgenic mice, the downregulation of the α1 subunit of AMPK played a relevant role in reducing TDP-43 mislocalization and the development (and progression) of ALS, suggesting AMPK-α1 as a potential drug target [69].